Share on StockTwits

ArthroCare Corp. (NASDAQ:ARTC) was downgraded by equities researchers at Craig Hallum from a “buy” rating to a “hold” rating in a research report issued on Tuesday, reports.

ArthroCare Corp. (NASDAQ:ARTC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $0.30 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.40 by $0.10. The company had revenue of $101.70 million for the quarter, compared to the consensus estimate of $100.53 million. During the same quarter last year, the company posted $0.30 earnings per share. ArthroCare Corp.’s revenue was up 5.0% compared to the same quarter last year.

A number of other analysts have also recently weighed in on ARTC. Analysts at BMO Capital Markets downgraded shares of ArthroCare Corp. from an “outperform” rating to a “market perform” rating in a research note on Monday. Separately, analysts at Northcoast Research downgraded shares of ArthroCare Corp. from a “buy” rating to a “neutral” rating in a research note on Thursday, January 9th. Finally, analysts at Canaccord Genuity raised their price target on shares of ArthroCare Corp. from $48.00 to $56.00 in a research note on Wednesday, January 8th. They now have a “buy” rating on the stock. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $49.67.

ArthroCare Corporation (NASDAQ:ARTC), is a medical device company.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.